In Episode 14 Piers and psychedelic researcher and activist Brett Greene discuss the future of psychedelic psychotherapy. Recorded on February 6, 2021.

Brett Greene is Chief Innovation Officer of Cybin, a leading biotechnology company focused on psychedelic therapeutics. Brett was co-founder of Psymposia a non-profit media organization that offers perspectives on drugs, politics, and culture. He also was the founder of Adelia Therapeutics a biopharmaceutical company dedicated to developing psychedelic therapeutics. You can find him on LinkedIn.

Resistance Recovery (RR) is reimagining addiction, recovery, and community in the 21st century. Piers Kaniuka, MTS, MS has worked with thousands of addicts and alcoholics in his 25+ years in the field. Discover RR's new paradigm of addiction recovery by visiting Resistance Recovery.

Visit the RR YouTube channel: https://www.youtube.com/c/RESISTANCERECOVERY

Sign-up for Long Threads and get Resistance Recovery news: https://mailchi.mp/ddc8023bec67/welcometoresistancerecovery

Support this podcast at — https://redcircle.com/resistance-recovery/donations